𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low-dose arabinosyl cytosine in acute leukemia after a myelodysplastic syndrome and in elderly leukemia

✍ Scribed by Emilio P. Alessandrino; Ester Orlandi; Ercole Brusamolino; Mario Lazzarino; Carlo Bernasconi

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
190 KB
Volume
20
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Low-dose cytosine arabinoside in the mye
Low-dose cytosine arabinoside in the myelodysplastic syndromes and acute myelogenous leukemia
✍ J. D. Roberts; W. B. Ershler; B. H. Tindle; J. A. Stewart πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 351 KB πŸ‘ 2 views

Seven patients with a myelodysplastic syndrome or "smoldering" acute myelogenous leukemia were treated with cytosine arabinoside in low dosage. Four patients experienced transient, partial responses characterized by improved peripheral blood counts, cessation of transfusion requirements, and a decre

Aleukemic leukemia cutis preceding overt
Aleukemic leukemia cutis preceding overt acute myeloid leukemia in myelodysplastic syndrome
✍ RodrΓ­guez, J.N.; Fernandez-Jurado, A.; Navarro, A.; Martino, M.L.; Prados, D. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 164 KB πŸ‘ 2 views

## Case of Schwachman's Syndrome With Intermittent Neutropenia and Lymphocyte Subset Disturbances To the Editor: Schwachman's syndrome, a familial disease transmitted as an autosomal-recessive trait, is characterized by moderate chronic neutropenia, marked marrow hypocellularity, occasional thromb

High dose cytosine arabinoside (HDARAC)
High dose cytosine arabinoside (HDARAC) in refractory acute leukemia
✍ Seth A. Rudnick; Edwin C. Cadman; Robert L. Capizzi; Roland T. Skeel; Joseph R. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 415 KB πŸ‘ 2 views

Thirteen leukemic patients with disease refractory to conventional chemotherapy were treated with 1.0 to 7.5 g/m2 of Cytosine Arabinoside (Ara-C) over 29 drug cycles. Drug infusions were spaced at 12-hour intervals; a maximum of four doses was administered over 36 hours. After single dose tolerance